Lv0
0 积分 2025-05-02 加入
(-)-Epigallocatechin-3-gallate reduces experimental colon injury in rats by regulating macrophage and mast cell
7个月前
已完结
The Potential of Epigallocatechin-3-gallate (EGCG) as Complementary Medicine for the Treatment of Inflammatory Bowel Disease
7个月前
已完结
エピガロカテキンガレートによる炎症性腸疾患保護効果
7个月前
已关闭
Gallic acid suppresses inflammation in dextran sodium sulfate-induced colitis in mice: Possible mechanisms
7个月前
已完结
Gallic acid suppresses inflammation in dextran sodium sulfate-induced colitis in mice: Possible mechanisms
7个月前
已完结
Colorectal cancer and inflammatory bowel diseases: effects of diet and antioxidants
7个月前
已关闭
The synergistic effect of epigallocatechin-3-gallate and quercetin co-loaded hydrogel beads on inflammatory bowel disease
7个月前
已完结
Therapeutic effects of epigallocatechin-3-gallate for inflammatory bowel disease: A preclinical meta-analysis
7个月前
已完结
Gallic acid attenuates LPS-induced inflammation in Caco-2 cells by suppressing the activation of the NF-κB/MAPK signaling pathway
7个月前
已完结
A DNA Nanopatch‐Bacteriophage System Targeting Streptococcus Gallolyticus for Inflammatory Bowel Disease Treatment and Colorectal Cancer Prevention
7个月前
已完结
皖公网安备34019202002308
